Long-term efficacy of immune checkpoint inhibitors with or without chemotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck: a commentary on the 4-year follow-up of the KEYNOTE-048 trial.

ABSTRACT:

SUBMITTER: Sano D 

PROVIDER: S-EPMC10248579 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature